Powder: -20°C for 3 years | In solvent: -80°C for 1 year
The compound effectively and directly inhibits JAK2 tyrosine kinase autophosphorylation and specifically inhibits ligand-dependent JAK2 activation. It has no cytotoxicity at 100 μM. A 16-hour treatment with compound (1 μM) decreases JAK2 tyrosine autophosphorylation levels to ~ 50% while 50 μM eliminates nearly all JAK2 activity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約6-8 週間 | ¥ 10,000 |
50 mg | 約6-8 週間 | ¥ 43,500 |
100 mg | 約6-8 週間 | ¥ 66,000 |
説明 | The compound effectively and directly inhibits JAK2 tyrosine kinase autophosphorylation and specifically inhibits ligand-dependent JAK2 activation. It has no cytotoxicity at 100 μM. A 16-hour treatment with compound (1 μM) decreases JAK2 tyrosine autophosphorylation levels to ~ 50% while 50 μM eliminates nearly all JAK2 activity. |
分子量 | 557.54 |
分子式 | C6H6Br6 |
CAS No. | 1837-91-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: > 8.2 mg/mL, Heating is recommended..
H2O: <1 mg/mL
Ethanol: <1 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
1,2,3,4,5,6-Hexabromocyclohexane 1837-91-8 Others 1,2,3,4,5,6Hexabromocyclohexane 1,2,3,4,5,6 Hexabromocyclohexane Inhibitor inhibitor inhibit